Study setting
The proposed study will be conducted as an open-label, randomized controlled clinical trial, at a selected residential care facility registered in the National Secretariat for Elders in Colombo, Sri Lanka. Two parallel study groups will include a treatment group and a control group in the same study setting. The study will start with a screening visit to check eligibility.